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High blood pressure is a well-established risk factor of dementia. However,
the timing of the risk remains controversial. The aim of the present study
was to compare trajectories of systolic blood pressure (SBP) over a 35-year
follow-up period in the Health Survey in Trøndelag (HUNT) from study wave
1 to 4 in people with and without a dementia diagnosis at wave 4 (HUNT4).
This is a retrospective cohort study of participants aged ≥ 70 years in HUNT4,
where 9,720 participants were assessed for dementia. In the HUNT study all
residents aged ≥ 20 years have been invited to four surveys: HUNT1 1984–86,
HUNT2 1995–97, HUNT3 2006–08 and HUNT4 2017–19. The study sample
was aged 70–102 years (mean 77.6, SD 6.0) at HUNT4, 54% were women and
15.5% had dementia, 8.8% had Alzheimer’s disease (AD), 1.6% had vascular
dementia (VaD) and 5.1% had other types of dementia. Compared to those
without dementia at HUNT4, those with dementia at HUNT4 had higher SBP
at HUNT1 and HUNT2, but lower SBP at HUNT4. These differences at HUNT1
and 2 were especially pronounced among women. Results did not differ
across birth cohorts. For dementia subtypes at HUNT4, the VaD group had
a higher SBP than the AD group at HUNT2 and 3. Age trajectories in SBP
showed that the dementia group experienced a steady increase in SBP until
65 years of age and a decrease from 70 to 90 years. SBP in the no- dementia
group increased until 80 years before it leveled off from 80 to 90 years.
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The present study confirms findings of higher midlife SBP and lower late-life
SBP in people with dementia. This pattern may have several explanations and
it highlights the need for close monitoring of BP treatment in older adults, with
frequent reappraisal of treatment needs.
KEYWORDS

blood pressure, dementia, trajectory, cohort study, Alzheimer, vascular dementia

association between midlife diastolic hypertension and AD risk,
the results regarding midlife systolic hypertension and AD
risk are conflicting (Walker et al., 2017). Few studies have
investigated the association between midlife hypertension and
risk of vascular dementia (VaD) but the association between
hypertension and risk of VaD seems to be more robust
than for AD (Walker et al., 2017). Sex differences in the
association between hypertension and dementia risk are not well
characterized and a recent review concluded that studies rarely,
and inconsistently analyzed or reported sex effects (Blanken and
Nation, 2020). Two recent studies indicated that sex differences
exist both for risk of dementia (Gong et al., 2021) and the risk of
memory decline (Anstey et al., 2021).
To be able to intervene in clinical settings, we need precise
information on patterns of how risk factors change over the life
course. However, very few studies have been able to follow the
trajectories of blood pressure from early or midlife until late life.
A recent review identified only four trajectory studies reporting
on risk of all-cause dementia and three studies reporting on risk
of AD or VaD. Only two of the studies had a follow-up longer
than 10 years (Peters et al., 2020).
The present study aims to test the hypothesis that midlife
hypertension is associated with dementia in late life, but that this
association is attenuated and even reversed with increasing age.
Furthermore, we hypothesize that different risk profiles exist
between men and women, older and younger age groups, and
between participants with AD and VaD.

Introduction
Dementia is a chronic, progressive syndrome which affects
cognition, behavior, and daily life functioning. The steeply
rising prevalence of dementia presents an immense individual,
societal and economic burden. In 2019, there were 57,4
million persons with dementia globally. This number is
projected to increase to 152,8 million by 2050 (GBD Dementia
Forecasting Collaborators, 2022). In Norway, 101,000 persons
have dementia, set to exceed 236,000 by 2050 (Gjøra et al.,
2021). With a few exceptions, such as antiretroviral therapy for
HIV-associated dementia, treatment of vascular diseases causing
dementia and the recently FDA approved monoclonal antibody,
aducanumab, there is at present no disease-modifying treatment
available for any of the diseases causing dementia. However,
modifiable lifestyle risk factors for dementia may be a target
for intervention. The recent Lancet commission on dementia
prevention, intervention and care identified 12 modifiable risk
factors and estimated that more than 40% of dementia cases
could be delayed or prevented by excluding these risk factors
(Livingston et al., 2020).
Hypertension is one of these risk factors. It has been
suggested that the observed decrease in dementia incidence
over the last decades is partly due to better blood pressure
(BP) control, especially in people with midlife hypertension
(Satizabal et al., 2016). Ample evidence suggests that midlife
hypertension is associated with an increased risk of dementia
(McGrath et al., 2017; Abell et al., 2018). However, as age
increases the association is attenuated and might even be
reversed. Previous studies have found that hypotension in old
age may be associated with an increased risk of dementia
(Hestad et al., 2005; Qiu et al., 2009; Gabin et al., 2017).
Alternatively, both late-life hypertension and hypotension may
be associated with an increased risk of dementia (Walker et al.,
2019). This may be due to reverse causality. The development
of degenerative brain disorder may induce a decrease in BP.
This is particularly relevant for the most common dementia
disorder, Alzheimer’s disease (AD), in which the degenerative
process starts in the brain decades before cognitive and
functional impairment become apparent (Frisoni et al., 2022).
The association between hypertension and risk of AD is still
not well understood. Whereas there seems to be a rather robust
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Materials and methods
Study population
In this retrospective cohort study, we employed data from
the Trøndelag Health (HUNT) study for our analyses. The
HUNT study is a unique database of questionnaire data,
clinical measurements, and biological samples from the former
Nord-Trøndelag county’s population from 1984 onward. The
study includes data from persons 20 years or older, gathered
during four waves: HUNT1 (1984–1986), HUNT2 (1995–
1997), HUNT3 (2006–2008), and HUNT4 (2017–2019). In
each HUNT wave, data were collected over a 2-year period
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LBD, FTD, mixed dementia, other specified dementia, and
unspecified dementia.
Time dependent covariates at HUNT1–4 included selfreported antihypertensive medication use (yes/no), daily smoker
(never, ever, current) and history of stroke (yes/no). Obesity was
defined as body mass index [calculated as weight (in kilograms)
divided by squared height (in meters)] ≥ 30 and included
as a dichotomous time dependent variable. Time invariant
covariates included the following: birth year, sex (male/female)
and education level (compulsory, secondary, tertiary) obtained
from the National Education Data Base (registry based data).
Missing values for education (n = 25) were imputed as
compulsory education. Missing values for history of stroke
(n = 70) for HUNT2–4 were imputed based on reports on
previous HUNT-study waves.

(Åsvold et al., 2022). In HUNT4 all participants who were
70 years and older were invited to participate in the HUNT4
70+ study (Gjøra et al., 2021) where they underwent cognitive
assessments.
Our study population included participants from the
HUNT4 70+ study, born 1914–49. Among a total of 9,904
participants, those with missing dementia assessment at HUNT4
(n = 178) and/or no BP measurements in any waves, HUNT1HUNT4 (n = 6) were excluded. A total of 9,720 individuals
were included in the analysis. In this study population of
HUNT4-participants, we studied systolic blood pressure (SBP)
trajectories retrospectively during the HUNT1-HUNT4 waves
and analyzed them by dementia status at HUNT4.

Procedures for diagnosis of dementia
or mild cognitive impairment

Procedures for blood pressure
assessment

In HUNT4 70+, dementia diagnoses were set by experts
from a diagnostic group of nine medical doctors with both
scientific and clinical expertise (geriatrics, neurology or old-age
psychiatry). A diagnosis was made for each case by two experts
independently, applying the DSM-5 diagnostic criteria to
classify the following conditions: no cognitive impairment, mild
cognitive impairment (mild neurocognitive disorder), dementia
(major neurocognitive disorder) and dementia subtypes;
AD, VaD, Lewy body dementias (LBD), frontotemporal
dementia (FTD), mixed dementia, other specified dementia
and unspecified dementia (Gjøra et al., 2021). If no consensus
for the diagnosis was reached a third expert was consulted.
During the diagnostic process the experts had access to all
relevant information from the HUNT4 70+ dataset, such as
cognitive tests, patient history, physical diseases including
stroke, function in activities of daily living, neuropsychiatric
symptoms assessment and a structured interview with the
closest family proxy.

At HUNT1 BP was assessed using a mercury
sphygmomanometer, by trained nurses or technicians. BP
was recorded twice in the seated position after resting for a
minimum of 5 min (Gabin et al., 2017). In HUNT1 the mean
of the first and the second readings was used to calculate mean
systolic or diastolic BP.
In HUNT2-HUNT4,
three repeated automated
oscillometric BP-measurements were recorded at 1-min
intervals. The measurements were started after the participant
was seated for 2 min with the cuff on the arm, and the arm
resting steadily on a table. The mean of the second and third
readings were used to calculate mean systolic or diastolic BP.
In HUNT2, measurements were done at the stationary
assessment team in the five larger municipalities by
oscillometry., using a Critikon Dinamap monitor (845XT
and XL9301) (Gabin et al., 2017).
In the HUNT3 study, BP and heart rate were measured using
a Critikon Dinamap (8,100) based on oscillometry (Krokstad
et al., 2013). Dinamap XL model 9301 (Johnson & Johnson
Medical Inc.) was also used for the measurements by the mobile
team in the 19 smaller municipalities in both HUNT2 and
HUNT3. The Dinamap XL model 9301 measures mean arterial
pressure directly, and hence does not estimate it from systolic
and diastolic pressure. In HUNT4 the Dinamap CARESCAPE
V100 (GE Healthcare) with GE TruSignal for pulse oximetry was
used, also based on automatic oscillometry.

Blood pressure, dementia status and
covariates
BP (mmHg) was measured in HUNT1–4. In the study
population 75% had BP measured at all waves (HUNT1–4),
90% had a BP measurement from at least 3 waves, 96% had
a BP measurement from at least two waves, and 4% had a BP
measurement from only one wave. Participants were included if
there was at least one valid BP measurement in HUNT1–4 and
a valid dementia assessment at HUNT4.
Dementia status was categorized as no dementia and
dementia. Dementia subtypes were categorized as AD, VaD
and “other dementia.” The category “other dementia” included
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Cognitive assessments
In HUNT4 70+ the following cognitive assessment
instruments were applied:
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and quadratic term and the interactions with dementia status
were included. The model was adjusted by all the adjustment
variables mentioned above and performed on the sample with
non-missing values for all the adjustment variables (n = 9484).
Since only two BP measurements were performed in
HUNT1 and three BP measurements were taken in HUNT2–
4, we did three sensitivity analyses using the same SBP
measurement at all surveys; first we used the first SBP
measurement at all surveys, secondly, we used the second
measurement at all surveys, and lastly we used the mean from
reading number one and two for all surveys.

The Montreal Cognitive Assessment (MoCA) scale is a
multidomain cognitive screening instrument that tests memory,
visuospatial and executive functions, naming, attention,
abstraction, language, and orientation. Scores range from 0 to
30; higher scores indicate better cognitive function (Nasreddine
et al., 2005).
The Word list from the Consortium to Establish a Registry
for Alzheimer’s Diseases (CERAD) (ten-word immediate and
delayed memory test) tests memory with a list of 10 words that
the person being tested is asked to recall after each of three initial
presentations (immediate recall) (score 0–30) and again after
10 min (delayed recall) (score 0–10) (Morris et al., 1989). In
nursing home patients with moderate to severe dementia, the
Severe Impairment Battery 8-item version was applied (Schmitt
et al., 2013).

Results
At HUNT4 the mean age was 77.6 years (SD 6.0) (range
70–102) and 54% were women. In 1984, the initial year of the
HUNT study (HUNT1), the mean age was 44.1 years (SD 6.4)
(range 35–70). During cognitive assessments at HUNT4, 1503
(15.5%) were found to have dementia, of which 856 (8.8%)
had AD, 156 (1.6%) had VaD and 491 (5.1%) had other types
of dementia. In the total sample, mean SBP increased from
129.2 (SD 15.9) mmHg in HUNT1 to 138.8 (SD 19.2) mmHg
in HUNT2 and remained stable from HUNT2 to HUNT3
(137.6 mmHg, SD 18.9) and HUNT4 (139.4 mmHg, SD 20.2).
Descriptive characteristics of the population from HUNT1 to
HUNT4, by dementia status at HUNT4 are presented in Table 1.

Ethics
This study was approved by the Regional Committee for
Medical and Health Research Ethics in Norway (REK Southeast
251687) and the Norwegian Center for Research Data (NSD
571736). Participation in the HUNT studies was based on an
informed written consent.

Statistical methods
Stata 16 was used for all analyses. SBP was used as the
outcome in a random intercept and random slope multilevel
mixed-effects linear regression model with HUNT study survey
as time variable (1–4) and dementia status at HUNT4 as
independent variable. Year of birth, sex, and educational level
were added to the model as time invariant adjustment variables,
while BP medication use, obesity, daily smoking, and history of
stroke were allowed to vary over the HUNT surveys 1–4 and
treated as time dependent covariates in the regression model. All
interactions between age, sex and dementia status were included.
SBP values by dementia status, sex and survey time point were
predicted from the regression model post hoc using the margins
command. Stratified predictions were performed to investigate
differences between men and women, between age groups (birth
years 1914–34 vs. 1935–49), and between dementia subtypes.
Analyses were run on the total study population (n = 9720)
in a minimally adjusted model with these variables included:
dementia, time, time∗ dementia, birth year, sex, as well as in the
study population with non-missing values for all the adjustment
variables (n = 9484).
In a second multilevel mixed-effects linear regression model
analysis (random intercept and random slope), age was used as
the time variable, thus the age trajectories by dementia status
at HUNT4 70+ were modeled. Age was included as a linear
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Systolic blood pressure trajectories by
all-cause dementia status at HUNT4,
adjusted for confounders
SBP from HUNT1 to HUNT4 comparing those with and
without dementia is presented in (Figure 1A) total sample
adjusted for sex and age, (Figure 1B) complete cases sample
adjusted for sex and age and (Figure 1C) complete cases fully
adjusted for sex, age, antihypertensive use, obesity, smoking
status and history of stroke.
Adjusted by sex and birth year (centered at 1939, and
45% men), the SBP trajectory for those with dementia, for
HUNT study waves 1–4 was 131.8, 143.3, 138.4, 132.2 mmHg,
respectively. For those without dementia the SBP trajectory
was 128.7, 137.9, 137.8, 140.7 mmHg from HUNT1–4
(Figure 1A). Thus, compared to those without dementia,
those with dementia at HUNT4, had higher SBP levels at
both HUNT1 (3.1 mmHg higher, 95%CI 2.1, 4.2) and at
HUNT2 (5.3 mmHg higher, 95%CI 4.3, 6.4) (Table 2). At
HUNT3 the SBP levels were similar (0.6 mmHg higher,
95%CI –0.6, 1.8), and at HUNT4 the pattern was reversed;
the BP level was 8.5 mmHg lower (95%CI –9.6, –7.3)
in the dementia group. In the sample with no missing
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TABLE 1 Characteristics of the study participants at the HUNT surveys (HUNT1–4: 1984, 1995, 2006, 2017) by dementia status (assessed at HUNT4).

Characteristic

No. of participants with
BP measurements
Age mean (SD), years

No dementia at HUNT4

Dementia at HUNT4

HUNT1
1984

HUNT2
1995

HUNT3
2006

HUNT4
2017

HUNT1
1984

HUNT2
1995

HUNT3
2006

HUNT4
2017

7,295

7,267

7,214

8,181

1,358

1,316

1,138

1,403

43.7 (5.7)

55.3 (5.7)

66.4 (5.6)

76.8 (5.5)

50.5 (7.5)

62.1 (7.5)

72.6 (7.1)

82.5 (7.2)

Women (%)

3,993 (54.7)

3,976 (54.7)

3,904 (54.1)

4,373 (53.4)

814 (59.9)

794 (60.3)

673 (59.1)

809 (57.7)

Men (%)

3,302 (45.3)

3,291 (45.3)

3,309 (45.9)

3,808 (46.6)

544 (40.1)

522 (39.7)

465 (40.9)

594 (42.3)

Education (%)
Compulsory

1,670 (22.9)

1,634 (22.5)

1,565 (21.7)

1,835 (22.4)

610 (44.9)

581 (44.1)

481 (42.3)

613 (43.7)

Secondary

3,200 (43.9)

3,169 (43.6)

3,142 (43.5)

3,475 (42.5)

517 (38.1)

509 (38.7)

434 (38.1)

535 (38.1)

Tertiary

2,425 (33.2)

2,464 (33.9)

2,507 (34.7)

2,871 (35.1)

231 (17)

226 (17.2)

223 (19.6)

255 (18.2)

Systolic BP mean (SD)
mm Hg

128.2 (15.2)

137.5 (18.4)

137.1 (18.5)

140.1 (19.9)

134.7 (18.2)

146.1 (21.7)

140.8 (20.7)

134.9 (21.6)

301 (4.1)

843 (11.6)

2,519 (34.8)

4,130 (65.7)

125 (9.1)

285 (21.6)

554 (48.4)

538 (65.2)

Current

1,595 (25.2)

1,507 (20.9)

814 (11.6)

493 (6.2)

313 (26.5)

269 (20.7)

121 (11.1)

71 (6.6)

Previous

1,837 (29.0)

2,497 (34.6)

2,971 (42.2)

4,025 (50.5)

303 (25.6)

430 (33.1)

432 (39.9)

536 (50.0)

Never

2,904 (45.9)

3,209 (44.5)

3,248 (46.2)

3,457 (43.4)

567 (47.9)

601 (46.2)

529 (48.9)

466 (43.4)

438 (6.0)

1,139 (15.7)

1,765 (24.4)

1,696 (21.4)

132 (9.7)

274 (20.9)

304 (26.8)

396 (29.9)

8 (0.1)

49 (0.7)

254 (3.5)

653 (8.8)

7 (0.5)

21 (1.6)

92 (8.0)

226 (23.2)

Antihypertensive use (%)
Smoking status (%)

Obesity (BMI > 30) (%)
History of stroke (%)

BMI, body mass index; BP, blood pressure; HUNT, The Trøndelag Health Study. Missing N in antihypertensive use: 1,007, 1,132, 1,330, 2,607 in HUNT1,2,3,4, respectively; missing N in
smoking status: 2,198, 1,207, 1,605, 672 in HUNT1,2,3,4, respectively; missing N in obesity: 1,070, 1,148, 1,362, 473 in HUNT1,2,3,4, respectively; missing N in history of stroke: 1,008,
1,131, 1,319, 1,363 in HUNT1,2,3,4, respectively.

Compared with the no dementia group, women in the
dementia group had a higher SBP at HUNT1 and HUNT2
and a lower SBP at HUNT4. There was no difference between
the groups at HUNT3. In men, SBP was higher in the
dementia group at HUNT2 and lower in the dementia group at
HUNT4, whereas there was no difference between the groups
at HUNT1 and HUNT3. The difference in SBP according to
dementia status at HUNT4, was significantly larger in women
compared to that in men at HUNT1 (p = 0.003) and HUNT2
(p < 0.001), while the difference was similar across sexes at
HUNT3 (p = 0.43) and HUNT4 (p = 0.72) (Figure 2A and
Table 2).
The difference in SBP according to dementia status at
HUNT4 was similar across birth cohorts (Figure 2B and
Table 2).
For those without dementia the SBP trajectory was 129.1,
137.8, 137.3, 139.7 mmHg from HUNT1–4 (almost identical
to the trajectories described above for the full sample). For
those with AD the SBP trajectory was 131.2, 141.3, 136.8,
134.0 mmHg from HUNT1–4, and for those with VaD the
SBP trajectory was 133.7, 147.7, 143.3, 137.6 mmHg from
HUNT1–4. Thus, there were substantial differences among
dementia subtypes. Compared to the no dementia group,
the VaD group had a higher SBP at HUNT1, HUNT2 and
HUNT3, but there was no difference at HUNT4. Compared

values for all confounders (n = 9,484), the SBP trajectories
by dementia status at HUNT4 were similar to the full
sample (N = 9,720), except that there was a slightly
smaller difference at HUNT4; the level was 5.3 mmHg
lower (95%CI –6.9, –3.8) in the dementia group (Figure 1B
and Table 2). In a fully adjusted model, with education,
antihypertensive medication, smoking, obesity and stroke,
results were minimally attenuated and almost identical to
those adjusted only for age and birth year (Figure 1C and
Table 2).

Systolic blood pressure trajectories by
dementia status at HUNT4: Differences
according to sex, birth cohort and
dementia subtype (fully adjusted
model, complete case sample
n = 9484)
The SBP difference between the no dementia group and
the dementia group at HUNT4, over the four HUNT waves
is shown in Figure 2 and Table 2, with stratification by
(Figure 2A) sex, (Figure 2B) birth cohort and (Figure 2C) type
of dementia.
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FIGURE 1

Systolic blood pressure trajectories by dementia status (yes/no) at HUNT4 70+ in 2017–19 with 95% confidence intervals. Multilevel mixed
methods with random intercept and slope. In the fully adjusted models in C, these time-dependent variables are included: blood pressure
medication (yes/no), smoking (current, previous, never), obesity (yes/no), and history of stroke (yes/no), and the following time-invariant
variables: education (compulsory, secondary, tertiary), birth year, and sex.

TABLE 2 Absolute difference in SBP (mmHg) at HUNT1, HUNT2, HUNT3 and HUNT4, respectively, for those with dementia at HUNT4 vs those
without dementia at HUNT4 (95% CI).

Number of participants (%)

HUNT1 1984

HUNT2 1995

HUNT3 2006

HUNT4 2017

Model 1

9,720

3.1 (2.1, 4.2)

5.3 (4.3, 6.4)

0.6 (–0.6, 1.8)

–8.5 (–9.6, –7.3)

Model 2

9,484

2.9 (1.8, 4.1)

5.0 (3.9, 6.0)

0.5 (–0.7, 1.7)

–5.3 (–6.9, –3.8)

Model 3

9,484

2.7 (1.6, 3.7)

4.6 (3.6, 5.7)

0.4 (–0.8, 1.6)

–5.2 (–6.7, –3.7)

Men

4,313 (45.5)

0.9 (–0.7, 2.6)

2.4 (0.7, 4.0)

–0.2 (–2.0, 1.6)

–5.0 (–7.3, –2.8)

Women

5,171 (54.5)

4.2 (2.8, 5.6)

6.2 (4.8, 7.6)

0.8 (–0.8, 2.3)

–5.6 (–7.6, –3.5)

Born 1935 or later

7,247 (76.4)

2.5 (0.9, 4.0)

4.5 (3.0, 6.1)

2.1 (0.4, 3.8)

–2.1 (–4.1, –0.01)

Born before 1935

2,237 (23.6)

4.3 (2.8, 5.9)

4.8 (3.2, 6.4)

1.4 (–0.4, 3.1)

–4.4 (–6.8, –2.0)

All

By sex (A), model 3

By birth cohort (B), model 3

Dementia type (C), model 3
No dementia
AD

8,037 (84.7)

–

–

–

–

831 (8.8)

2.1 (0.8, 3.5)

3.4 (2.1, 4.8)

–0.6 (–2.1, 0.9)

–5.7 (–7.7, –3.7)

VaD

147 (1.5)

4.6 (1.6, 7.6)

9.9 (6.9, 12.9)

6.0 (2.6, 9.3)

–2.1 (–6.2, 2.0)

Other dementias

469 (4.9)

3.0 (1.3, 4.8)

5.2 (3.4, 7.0)

0.6 (–1.4, 2.6)

–5.2 (–7.8, –2.6)

Model 1 Total sample (N = 9,720), age and sex adjusted; Model 2 Complete cases sample (N = 9,484), age and sex adjusted; Model 3 Complete cases sample (N = 9,484), adjusted by age,
sex, education, and histories of blood pressure medication, smoking, obesity, and stroke.

mmHg higher, p < 0.001) and HUNT3 (6.5 mmHg higher,
p < 0.001) (Figure 2C and Table 2). The VaD group had
similar SBP as the AD group at HUNT1 (p = 0.14) and HUNT4
(p = 0.12).

to the no dementia group, the AD group had a higher SBP
at HUNT1, HUNT2 and a lower SBP at HUNT4. There was
no difference at HUNT3. Those with VaD had significantly
higher SBP than those with AD, both at HUNT2 (6.5
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FIGURE 2

Trajectories in difference in systolic blood pressure between those with dementia at HUNT4 70+ (2017–19) vs those without dementia
(reference line 0) by sex, birth cohort, and dementia type (restricted to AD and VaD) with 95% confidence intervals. Multilevel mixed methods
with random intercept and slope. In all models, these time-dependent variables are included: blood pressure medication (yes/no), smoking
(current, previous, never), obesity (yes/no), and history of stroke (yes/no), and the following time invariant variables: education (compulsory,
secondary, tertiary), birth year, and sex.

Using the first BP measurement across all HUNT
surveys 1–4, instead of the mean of two readings,
shifted the BP slightly upwards for all groups. Thus,

The SBP of the “other dementias” group did not differ from
the AD group from HUNT1-HUNT4 (Table 2).

Age trajectories
Fully adjusted age trajectories in SBP between those with and
without dementia at HUNT4 70+ are presented in Figure 3. By
visual inspection we saw in the dementia group a steady increase
in SBP until 65 years of age, a stable level from 65 to 70 and a
steady decrease from 70 to 90 years of age. In the no dementia
group we saw that SBP increased until age 80 before it leveled off
from 80 to 90.
Compared to the no dementia group the dementia group
had higher SBP from 45 to 75 years of age. At 80 and 85 years
of age there was no difference between the groups and at
90 years of age the dementia group had lower SBP than the
no dementia group.

FIGURE 3

Age trajectories in systolic blood pressure between those with
dementia at HUNT4 70+ (2017–19) vs those without dementia
with 95% confidence intervals. Multilevel mixed methods with
random intercept. In all models, these time-dependent variables
are included: blood pressure medication (yes/no), smoking
(current, previous, never), obesity (yes/no), and history of stroke
(yes/no), and the following time invariant variables: education
(compulsory, secondary, tertiary), and sex.

Sensitivity analyses
Using alternative BP measurements in the analyses
did not impact the main findings (results not shown).
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Chronic hypertension may also disrupt blood-brain-barrier
(BBB) function impeding transport of essential substances into
the brain and transport of waste products out of the brain.
Furthermore, BBB disruption promotes neuroinflammation,
synaptic dysfunction and myelin damage contributing to
cognitive decline and dementia and exacerbate amyloid
pathologies associated with Alzheimer’s disease (Ungvari
et al., 2021). Chronic hypertension is also associated with
arteriosclerosis and cardiac failure, both conditions which
may negatively affect cerebral blood flow and thereby cause
cognitive decline. Long-standing hypertension may induce a
state of hypoperfusion in the brain. It has been postulated that
brain hypoperfusion is involved in the pathogenesis of AD, by
constituting an upstream event before amyloid formation (De la
Torre, 2018).
There might be several explanations as to why midlife
hypertension, but not late-life hypertension is associated
with dementia. Hypertension usually begins long before the
neurodegenerative process and it acts as a powerful contributor
to cognitive impairment in midlife (Veldsman et al., 2020).
While hypertension is one of very few contributors to cognitive
impairment in midlife, its contribution might be obscured by
several other factors in late life, such as neurodegeneration
because of AD. Other factors associated with development
of dementia, such as people with dementia becoming more
immobile, more fragile and being underweight, might in
combination contribute to a decrease in blood pressure along
the disease course. Recently, a new evolutionary interpretation
of the brain’s circulation has been proposed, indicating that
the brain circulation comprises complementary low-pressure
and high-pressure systems (the ambibaric brain). This model
highlights the need for the development of methods of assessing
the best blood pressure for the individual brains and for close
monitoring of BP to optimize brain health (Hachinski and
Østergaard, 2021).
Most previous studies report that dementia and AD are
more common in women than in men whereas VaD is more
common in men (Cao et al., 2020). This was also found in
our recent study using the same HUNT4 70+ group as the
present study (Gjøra et al., 2021). Suggested explanations for
this sex difference include longevity (women live longer than
men), biological differences (hormones, epigenetics, frailty),
differences in cognitive performance and gendered social roles
and opportunities (Andrew and Tierney, 2018). Recent studies
have indicated that sex differences in dementia prevalence may
be influenced by sex differences in the profile of dementia
risk factors. A recent review concluded that higher midlife
SBP was associated with a greater risk of all-cause dementia,
AD and VaD in women compared to men (Blanken and
Nation, 2020). Another recent study found that mid-adulthood
hypertension was associated with increased dementia risk in
women, but not in men (Gilsanz et al., 2017). A large UK
biobank study found that the association between several midlife

the choice of BP measure was robust and did not affect
our conclusions.

Discussion
In this retrospective population-based cohort study, we
found that persons with dementia had a higher SBP in HUNT1HUNT2 but a lower SBP in HUNT4. The decrease in SBP in the
dementia group started 10–20 years prior to dementia diagnosis
at HUNT4. The results were largely confirmed in both the AD
and VaD groups. Although the overall pattern of SBP trajectories
remained the same across sex and age groups, some differences
between groups were observed.
A pattern with higher BP in midlife but lower BP in late
life in persons with dementia, compared to persons without
dementia was demonstrated in the seminal study by Skoog et al.
(1996) and has later been confirmed in several studies (Qiu et al.,
2005; Li et al., 2007; Abell et al., 2018). However, studies on
midlife hypertension cover a wide age range. Also in the present
study, the age range of the participants at each assessment spans
more than 30 years. However, when considering the sample
in two age groups (35–49 and 50–70 years at HUNT1), we
found that the pattern with higher SBP at HUNT1 and HUNT2
and lower SBP at HUNT4, in those with dementia at HUNT4
remained the same in both age groups. When modeling age
trajectories of SBP we found substantial differences between
the groups. The dementia group had an increase in SBP until
the age of 70 and a significant drop in SBP afterward. The no
dementia group experienced a slower increase in SBP but no
significant drop in SBP in old age. These findings indicate that
higher SBP is associated with an increased risk for dementia
over a long period, from 45 years until 75 years of age and
that it is only in later life that lower SBP is associated with a
higher risk of dementia. These findings highlight the importance
of monitoring SBP closely in older people with dementia as
antihypertensive medication might need to be adjusted or even
deprescribed to avoid negative outcomes, such as increased
morbidity and mortality (Benetos et al., 2015). Furthermore,
current evidence does not show any clear benefit of initiation of
antihypertensive treatment in older age groups (Benetos et al.,
2019).
Potential mechanisms that may explain the association
between hypertension and dementia risk are multifaceted.
It seems that higher BP and older age have a synergistic
deleterious effect on the structural and functional integrity of the
cerebral microcirculation (Ungvari et al., 2021). Hypertension
leads to dysregulation of cerebral blood flow. This in turn
exposes the cerebral microvessels to hemodynamic instability
causing pathological changes termed small vessel disease.
This includes endothelial dysfunction, lipohyalinosis, fibrinoid
necrosis, lacunes and microhaemorrhages (McGrath et al.,
2017). All these events are associated with cognitive decline.
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including nursing-home patients, the sample covers all
levels of dementia. Furthermore, BP was measured in
a standardized way and 75% of the participants had BP
measurements at all four assessments. We were able to adjust
for several potential confounders, limiting the chance of
residual confounding.
There are a few limitations that should be taken into
consideration when interpreting the results. We did not have
information about race/ethnicity. However, recent reports show
that only 1.6% of the population 67 + in the catchment area
of the present study had a minority background (StatBank
Norway, 2022). Hence, the present results may not be
generalized to groups beyond a Nordic population. Although
the diagnostic process conforms to the quality indicators
of population-based dementia studies, the reliance on data
collected by others and the lack of biomarker data may
make the diagnosis less valid, especially regarding subtypes of
dementia. The lack of cognitive assessments prior to HUNT4
is a major limitation. It is reasonable to assume that the
participants did not have dementia at HUNT1 and HUNT2
and that very few if any had dementia at HUNT3. However,
it is difficult to gauge the importance of reverse causality,
especially because of disease development in the preclinical
stage in some of the dementia subtypes. Even though the
participation rate is relatively high, some selection bias is
likely. A study on non-participation in HUNT3 showed that
those who did not participate had lower socioeconomic status,
higher mortality and a higher prevalence of chronic diseases
(Krokstad et al., 2013). Another limitation is the substantial
amount of self-reported data, which is inherent to most
large-scale population studies. Even though we have adjusted
for the most common confounders residual confounding
cannot be excluded. Finally, our study may be prone to
survival bias. This would most likely attenuate the association
between the exposure in midlife (BP) and the outcome
(dementia).

cardiovascular risk factors and risk of dementia did not differ
between the sexes, but BP affected men and women differently.
The relationship between higher SBP and dementia risk was
U-shaped in men but had a dose-response relationship in
women. This difference was not affected by antihypertensive
use and was consistent across dementia subtypes, like AD
and VaD (Gong et al., 2021). Our study strengthens the idea
that sex differences exist since SBP was higher at HUNT1
in the dementia group only in women. Furthermore, the
difference in SBP between those with and without dementia was
larger in women than in men at both HUNT1 and HUNT2.
These differences remained when the analysis was adjusted for
antihypertensive use and other risk factors which may differ
between the sexes.
The association between midlife hypertension and AD risk
is unclear, with most studies showing consistent association
between increased midlife diastolic BP and AD risk, whereas
studies regarding increased midlife BP and AD risk are
conflicting. An association between late-life hypotension and
AD risk has been documented in several studies (Walker et al.,
2017). Our study confirms a clear pattern of SBP trajectory
and AD risk, where a higher SBP in midlife and a lower
SBP in late life was associated with a diagnosis of AD in late
life.
The evidence supporting an association between midlife
hypertension and increased VaD risk is stronger than for
AD risk but the results regarding BP and VaD risk in old
age are conflicting. Only a few studies have addressed this
specifically (Walker et al., 2017). A registry-based study of
4.28 million individuals found that higher SBP was associated
with increased VaD risk, irrespective of preceding transient
ischemic attack or stroke but no inverse association in old
age (Emdin et al., 2016). Our findings confirm that people
with VaD have higher SBP in midlife than those with AD.
Additionally we found that SBP decreases substantially in the
VaD group with increasing age. However, not to the extent
that VaD was associated with lower SBP compared to the no
dementia group, as observed in the AD group at HUNT4.
Comparisons between the AD and VaD group should be
interpreted with caution as there probably is considerable
overlap with a large group of people with mixed AD and
VaD pathology (Custodio et al., 2017). One could argue that
most dementias constitute a mix, often including AD pathology
with a typical case harboring several pathologies (Boyle et al.,
2018).

Conclusion
In the present study, dementia was associated with systolic
hypertension in midlife but not in late life. In general, the same
pattern existed across sex, age groups and types of dementia
although some variation was apparent. Our findings underline
that the trajectories of blood pressure should be closely
monitored in clinical practice and the need for continuing
antihypertensive treatment should be reappraised regularly.
Separate blood pressure targets for men and women may need
to be developed. To identify the ideal blood pressure for the
individual brain is an urgent question in personalized medicine.
Future studies should also include measurements of standing
and sitting/lying blood pressure since orthostatic instability may
contribute to the cognitive impairment.

Strengths and limitations
The main strength of the present study is the large
population-based sample, a follow-up period of more
than 30 years and a thorough consensus-based method
for diagnosing dementia and subtypes of dementia. By
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